The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls
10 notices naming The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories as the recalling firm, since November 20, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Major ChlorproMAZINE Hydrochloride Tablets and 4 more
Hazard (FDA): CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Sulfamethoxazole and Trimethoprim and 1 more
Hazard (FDA): Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was…
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Carvedilol Tablets USP
Hazard (FDA): CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: ChlorproMAZINE Hydrochloride Tablets
Hazard (FDA): CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
FDAMedicines
Dissolution
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Tolterodine Tartrate Extended-Release Capsules
Hazard (FDA): Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Lorazepam Tablets and 2 more
Hazard (FDA): Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
FDAMedicines
Dissolution
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Potassium Chloride Extended-Release Tablets
Hazard (FDA): Failed Dissolution Specifications.
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Duloxetine Delayed-Release Capsules USP
Hazard (FDA): CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Guaifenesin Dextromethorphan Syrup and 1 more
Hazard (FDA): Failed Impurity/Degradation Specifications
FDAMedicines
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories: Hydralazine HCl Tablets
Hazard (FDA): Failed Impurities/Degradation Specifications; during routine stability testing for impurities.
FDAMedicines